A, common, measure, dividend, sustainability, payout, ratio, percent, earnings, paid, shareholders, Unfortunately, earnings, always, represent, much, money, available, management, include, noncash, items, That, free, cash, flow, left, sales, expense, running, business, buying, maintaining, physical, assets, provide, useful, way, gauge, much, company, could, pay, likely, dividend, cut, might, For, high, yielders, threat, like, Realty, Income, NYSE, O, ExxonMobil, NYSE, XOM, Gilead, Sciences, NASDAQ, GILD, comparing, free, cash, flow, dividends, helps, us, determine, easily, company, keep, doling, cash, working, obstacles, 
Known, monthly, dividend, company, Realty, Income, owns, 6, 000, properties, largest, categories, convenience, dollar, stores, drug, stores, well, gyms, theaters, The, company, offers, triple, net, leases, meaning, tenants, pay, taxes, insurance, maintenance, property, 
The, arrangements, worked, brilliantly, company, allowing, pay, monthly, dividend, increased, 92, straight, quarters, That, monthly, payout, 0, 2345, currently, translates, 4, 7, annualized, yield, While, dividend, climbed, 60, 2015, 2019, revenue, earnings, per, share, increased, 46, 27, respectively, 
With, quarterly, increases, outpacing, sales, math, catching, company, retail, categories, hampered, pandemic, Theaters, make, nearly, 7, leases, hit, especially, hard, management, estimating, half, ever, catch, rent, Because, hit, property, rent, dropped, 4, 4, recent, quarter, ended, Sept, 30, With, decline, free, cash, flow, approaching, amount, dividends, paid, 
DATA, SOURCE, MORNINGSTAR, TABLE, BY, AUTHOR, TTM, TRAILING, 12, MONTHS, 
The, danger, may, soon, Box, office, revenue, returned, 80, pre, pandemic, levels, virus, control, China, As, long, cases, U, S, continue, trending, downward, dividend, safe, A, longer, term, threat, could, e, commerce, Digital, sales, grew, 36, first, two, weeks, December, compared, 2019, That, trend, means, less, need, retail, stores, could, undermine, company, business, model, next, While, Realty, Income, looks, like, reliable, dividend, payer, company, faces, short, term, long, term, risks, could, change, 
Since, revenue, peaked, oil, giant, 2011, fallen, 46, 256, billion, 2019, That, pandemic, put, dent, oil, intensive, business, travel, commutes, For, first, nine, 2020, sales, 135, billion, another, 32, 2019, The, stock, fallen, even, sales, yields, 7, 4, 3, 48, per, That, massive, yield, came, scrutiny, 2020, company, continued, streak, raising, payout, 37, consecutive, Falling, free, cash, flow, rising, payouts, pushed, Exxon, unsustainable, territory, 
DATA, SOURCE, MORNINGSTAR, TABLE, BY, AUTHOR, TTM, TRAILING, 12, MONTHS, 
It, remains, seen, whether, management, signal, dividend, increase, April, typically, In, meantime, Exxon, taking, serious, action, preserve, cash, Last, company, announced, cutting, 2020, capital, spending, 30, reducing, global, workforce, 15, next, two, On, top, moves, management, suspended, employee, benefit, programs, like, 401, k, match, 
With, oil, consumption, expected, reach, pre, pandemic, levels, 2023, spending, cuts, may, enough, For, yield, seeking, investors, longer, company, pays, attractive, dividend, riskier, financial, situation, becomes, Anyone, buying, shares, prepared, possible, dividend, cut, near, future, curbs, spending, limit, ExxonMobil, long, term, growth, ability, attract, talent, 
The, company, best, known, HIV, hepatitis, C, HCV, drugs, seen, sales, fall, 30, peak, 2015, 23, 2, billion, past, 12, With, dividend, 2, 72, per, 4, 1, yield, Gilead, offers, attractive, payout, However, declining, sales, recipe, sustaining, growing, dividend, long, term, Revenue, stabilized, fiscal, 2020, thanks, Veklury, brand, name, Remdesivir, used, treat, patients, COVID, 19, one, knows, long, last, 
As, patients, shied, away, checkups, screening, fear, COVID, sales, Gilead, HCV, drugs, fell, 47, 31, second, third, quarters, 2020, respectively, Veklury, filled, gap, In, December, half, COVID, patients, U, S, received, treatment, That, despite, warning, World, Health, Organization, failed, show, enough, evidence, four, global, trials, support, use, While, Veklury, kept, Gilead, bringing, plenty, cash, keep, paying, dividend, outlook, remains, murky, 
DATA, SOURCE, MORNINGSTAR, TABLE, BY, AUTHOR, TTM, TRAILING, 12, MONTHS, 
The, company, spent, 26, billion, two, large, acquisitions, 2020, bolster, oncology, pipeline, hopes, reversing, falling, sales, It, need, success, Kite, Pharma, purchased, 12, billion, 2017, Since, deal, management, written, value, Kite, 820, million, twice, 
For, investors, breathe, easy, long, Veklury, continues, play, sizable, role, fighting, COVID, U, S, even, unpredictable, Just, week, San, Francisco, based, research, team, identified, cancer, drug, may, 30, times, better, fighting, COVID, Gilead, drug, To, continue, raising, dividend, beyond, next, Gilead, need, prove, monetize, new, oncology, pipeline, get, drug, market, turn, negative, sales, trend, around, 
